Co-Authors
This is a "connection" page, showing publications co-authored by Paolo Gisondi and D Thaçi.
Connection Strength
0.956
-
Low incidence rate of respiratory and viral infections over 5 years of treatment with tildrakizumab in patients with moderate-to-severe psoriasis: pooled analysis from reSURFACE 1 and reSURFACE 2 phase 3 trials. J Eur Acad Dermatol Venereol. 2021 Nov; 35(11):e709-e711.
Score: 0.956